ECU
TWST icon

Eisler Capital (US)’s Twist Bioscience TWST Stock Holding History

Eisler Capital (US)’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-40,438
Closed -$1.99M – 672
2024
Q2 		$1.99M Buy
+40,438
New +$1.65M 0.04% 356

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Eisler Capital (US)'s TWST Position: Q3 2024 in Review

Eisler Capital (US) sold out of Twist Bioscience (TWST) in Q3 2024, closing a stake of 40,438 shares — an estimated $1.99M sold.

Eisler Capital (US) first reported a position in TWST in Q2 2024 and held it in 1 quarter. The position peaked at $1.99M in Q2 2024. 246 funds tracked by Wall St. Rank hold TWST as of Q3 2024.

  • Eisler Capital (US) reported no remaining Twist Bioscience position as of Q3 2024 after selling out during the quarter.
  • Eisler Capital (US) sold 40,438 Twist Bioscience shares in Q3 2024, an estimated $1.99M.
  • Eisler Capital (US) first reported a position in Twist Bioscience in Q2 2024 and held it in 1 quarter.
  • Eisler Capital (US)'s Twist Bioscience position peaked at $1.99M in Q2 2024.
  • 246 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.